Breaking Down Cyient Limited Financial Health: Key Insights for Investors

IN | Industrials | Conglomerates | NSE

Cyient Limited (CYIENT.NS) Bundle

Get Full Bundle:
$25 $15
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7
$9 $7

TOTAL:

Investors tracking Cyient Limited will want to dig into a mixed set of metrics: the DET segment reported FY25 revenue of ₹5,816 crore (a 1.6% decline year‑on‑year) with an EBIT margin of 13.5% (down 261 bps), consolidated Q4 revenue hit ₹1,950.2 crore (up 3.5% YoY) even as Q3 net profit plunged to ₹122.3 crore (down 31.7% QoQ) and FY25 consolidated net profit fell 9.8% to ₹615.7 crore; other pressure points include a slide in EBITDA margin to ~16.9% (Q4 FY25 vs 20.1% a year ago), EPS easing to ₹55.51 from ₹61.71, and a 24% stock drop to ₹1,328.90 after the CEO's resignation - yet liquidity shows resilience with record free cash flow of ₹801 crore in FY25 and the board still declaring an interim dividend of ₹16 per share, while broker targets span ₹1,050-₹2,197, underscoring the trade‑offs investors must weigh across valuation, debt, guidance downgrades and growth initiatives like the semiconductor carve‑out.

Cyient Limited (CYIENT.NS) - Revenue Analysis

Key revenue dynamics for Cyient Limited (CYIENT.NS) in FY25 and Q3-Q4 FY25 signal mixed momentum across consolidated and segment levels, with Digital, Engineering & Technology (DET) under pressure versus prior expectations.

  • FY25 DET reported revenue: ₹5,816 crore (decline of 1.6% YoY).
  • FY25 DET EBIT margin: 13.5% (down 261 basis points YoY).
  • Q3 FY25 consolidated revenue: ₹1,926.4 crore (up 4.2% QoQ).
  • Q4 FY25 consolidated revenue: ₹1,950.2 crore (up 3.5% YoY).
  • Q4 FY25 DET revenue: ₹1,480 crore (up 2.1% QoQ; down 0.8% YoY).
  • FY25 DET revenue guidance revised to a decline of 2.7% (from prior flat guidance).
Period Consolidated Revenue (₹ crore) DET Revenue (₹ crore) DET EBIT Margin Change
FY25 (DET, full year) - 5,816 13.5% DET YoY: -1.6%; EBIT margin: -261 bps YoY
Q3 FY25 (Consolidated) 1,926.4 - - QoQ: +4.2%
Q4 FY25 (Consolidated) 1,950.2 1,480 13.5% (DET) Consol YoY: +3.5%; DET QoQ: +2.1%; DET YoY: -0.8%
FY25 Guidance (revised) - - - DET revenue growth: -2.7% (revised down from flat)

For investor context and ownership trends related to Cyient Limited (CYIENT.NS), see: Exploring Cyient Limited Investor Profile: Who's Buying and Why?

Cyient Limited (CYIENT.NS) - Profitability Metrics

Cyient's recent profitability profile shows pressure on margins and quarterly earnings, with pockets of strength in specific segments like Design Led Manufacturing (DLM).
  • Q3 FY25 net profit: ₹122.3 crore, down 31.7% sequentially.
  • Q2 FY26 net profit: ₹142.9 crore, down 23.4% year-on-year.
  • Consolidated net profit FY25: ₹615.7 crore, down 9.8% year-on-year.
  • Interim dividend declared in Q2 FY26: ₹16 per equity share despite reduced profits.
  • DLM segment: Profit after tax increased driven by volume growth and a new acquisition.
Period Net Profit (₹ crore) Change EBITDA Margin
Q3 FY25 122.3 -31.7% vs Q2 FY25 -
Q4 FY24 - - 20.1%
Q4 FY25 - - 16.9%
Q2 FY26 142.9 -23.4% YoY -
FY25 (Consolidated) 615.7 -9.8% YoY -
Key margin and profitability drivers observed:
  • EBITDA margin compression from 20.1% in Q4 FY24 to ~16.9% in Q4 FY25, indicating margin stress across operations.
  • Sequential quarterly net profit volatility (example: Q3 FY25 down 31.7% from prior quarter) suggesting demand or cost fluctuations.
  • DLM's PAT uplift highlights inorganic & volume-led contributions that partially offset softness in other services.
  • Shareholder return maintained via a ₹16 interim dividend in Q2 FY26 despite declining earnings, reflecting cash generation and capital allocation priorities.
For context on strategic priorities that may affect future profitability, see: Mission Statement, Vision, & Core Values (2026) of Cyient Limited.

Cyient Limited (CYIENT.NS) - Debt vs. Equity Structure

Cyient Limited's capital structure in FY25 reflects a leveraged yet controlled profile, with finance costs representing a modest portion of overall outflows even as strategic moves reshape the business mix.
  • Finance costs FY25: ₹928 crore (1.3% of total expenses).
  • Total expenses FY25: ₹65,771 crore.
  • Profit before tax (consolidated) FY25: ₹8,750 crore, down 4.7% year-on-year.
  • Interim dividend declared Q2 FY26: ₹16 per equity share despite profit decline.
  • Corporate restructuring: carve-out of semiconductor business into Cyient Semiconductors Private Limited (fully owned subsidiary).
Metric FY25 Notes / YoY Movement
Total expenses ₹65,771 crore Finance costs are a small component
Finance costs ₹928 crore ≈1.3% of total expenses
Profit before tax (consolidated) ₹8,750 crore Down 4.7% vs prior year
Interim dividend (Q2 FY26) ₹16 per share Paid despite lower profits
Key corporate action Carve-out Semiconductor business → Cyient Semiconductors Private Limited
Debt-versus-equity dynamics and operational drivers:
  • Debt burden: implied moderate given finance costs' small share (₹928 crore) of large expense base (₹65,771 crore), suggesting efficient use of leverage or low average borrowing cost.
  • Equity policy: shareholder-friendly - interim dividend of ₹16/share in Q2 FY26 signals capital return priority despite PBT decline.
  • Profitability pressures: PBT fell 4.7% to ₹8,750 crore in FY25, indicating margin headwinds even as absolute earnings remain substantial.
  • Segmental shifts: DLM segment saw PAT increase driven by volume growth and a recent acquisition, supporting earnings resilience.
Implications for investors (capital-structure focus):
  • Low relative finance cost reduces interest-rate sensitivity and preserves operating cash flow for reinvestment or dividends.
  • Carve-out of semiconductor operations into a wholly owned subsidiary improves transparency of capital allocation and may enable targeted funding or external investment for that unit.
  • Dividend continuation during profit weakness reflects either strong free cash flow or strategic desire to sustain investor confidence; assess sustainability against cash generation metrics.
  • Monitor future FY26 financials for any uptick in finance costs if acquisition financing or subsidiary capital needs increase.
Reference: Cyient Limited: History, Ownership, Mission, How It Works & Makes Money

Cyient Limited (CYIENT.NS) - Liquidity and Solvency

Key liquidity and solvency datapoints for FY25 and Q2 FY26 highlight a company generating strong cash while facing modest pressure on operating profitability.

  • Free cash flow (FCF) in FY25: ₹801 crore - highest on record, up 6.2% year‑on‑year (FY24 FCF ≈ ₹755 crore).
  • Profit before tax (consolidated) in FY25: ₹8,750 crore - down 4.7% vs FY24 (FY24 PBT ≈ ₹9,184 crore).
  • Interim dividend declared: ₹16 per equity share in Q2 FY26, signalling cash return to shareholders despite PBT decline.
Metric FY24 (approx.) FY25 (reported) YoY % change
Profit Before Tax (consolidated) ₹9,184 crore ₹8,750 crore -4.7%
Free Cash Flow ₹755 crore ₹801 crore +6.2%
Interim Dividend (Q2 FY26) - ₹16 per share -
  • Cash generation vs. profitability: FCF growth (+6.2%) contrasts with a small decline in PBT (-4.7%), indicating operational cash resilience even as margins/earnings saw pressure.
  • Dividend policy signal: A ₹16 interim dividend in Q2 FY26 demonstrates management's willingness to deploy cash to shareholders while maintaining liquidity.
  • Solvency considerations: Persistent positive FCF supports debt servicing and capital allocation; monitoring future PBT trends is key for long‑term solvency if earnings pressure continues.

Further context on the company's strategy, ownership and how it generates revenue is available here: Cyient Limited: History, Ownership, Mission, How It Works & Makes Money

Cyient Limited (CYIENT.NS) - Valuation Analysis

  • Market reaction: Stock fell 24% to ₹1,328.90 after the CEO resignation and downward guidance for FY25.
  • EPS trend: FY25 EPS was ₹55.51 versus FY24 EPS of ₹61.71, indicating an earnings decline of ~10.1% year-over-year.
  • Implied trailing P/E (using FY25 EPS and current price ₹1,328.90): ~23.95x.
Analyst / Source Action / Rating Target Price (₹) Notes
Nuvama Institutional Equities Revised target 1,660 Cut from ₹1,700; cited lower growth and margins
HDFC Institutional Equities ADD 1,790 Based on 22x FY27E DET EPS
Motilal Oswal Sell 1,120 Reduced target due to weak growth and underwhelming margins
Consensus - 1,377 Range: ₹1,050 to ₹2,197
  • Valuation context: Consensus target (₹1,377) implies upside of ~3.6% from current price (₹1,328.90); targets range implies wide analyst uncertainty (low ₹1,050, high ₹2,197).
  • EPS deterioration and management change materially compress valuation multiples versus prior expectations; HDFC's FY27E basis suggests expectations of recovery by then.
  • Key reference: Exploring Cyient Limited Investor Profile: Who's Buying and Why?

Cyient Limited (CYIENT.NS) - Risk Factors

The following risk factors capture material near-term and structural risks for Cyient Limited (CYIENT.NS) that investors should weigh alongside valuation and strategic outlook.
  • Leadership disruption: CEO Karthikeyan Natarajan resigned in January 2025; Krishna Bodanapu is serving as interim CEO - governance and execution continuity risk.
  • Revenue guidance cut: FY25 DET (Design, Engineering & Technology) revenue growth guidance was revised to a 2.7% decline from earlier flat guidance, indicating demand softness.
  • Profit compression: Net profit for Q3 FY25 was ₹122.3 crore, down 31.7% quarter-on-quarter, signaling margin and volume pressures.
  • Margin deterioration: EBITDA margin fell to ~16.9% in Q4 FY25 from 20.1% in Q4 FY24, narrowing operating cushion versus peers.
  • Share-price sensitivity: The stock dropped 24% to ₹1,328.90 following the CEO departure and lowered guidance, highlighting market reaction risk.
  • Capital allocation vs earnings: Despite profit decline, the company declared an interim dividend of ₹16 per share in Q2 FY26 - potential stress on cash flow if earnings remain under pressure.
  • Execution risk on turnaround: Restoring top-line growth and margins depends on stabilizing leadership, cost control, and contract delivery in a competitive outsourcing market.
  • Client concentration and macro exposure: Any slowdown among key customers or adverse macro conditions could amplify revenue downside given recent guidance cut.
Metric Value / Change
CEO status Karthikeyan Natarajan resigned Jan 2025; Krishna Bodanapu interim CEO
FY25 DET guidance Revised to -2.7% (from flat)
Q3 FY25 net profit ₹122.3 crore (down 31.7% QoQ)
EBITDA margin Q4 FY25: ~16.9% vs Q4 FY24: 20.1%
Interim dividend ₹16 per equity share declared in Q2 FY26
Stock price reaction Declined 24% to ₹1,328.90 after CEO exit & lowered guidance
  • Financial sensitivity scenarios investors should model:
    • Base: DET revenues decline ~2.7% FY25, margins remain near Q4 FY25 levels (EBITDA ~16.9%).
    • Downside: Continued revenue pressure → further margin compression and cash flow strain if dividend policy persists.
    • Recovery: Stabilized leadership + cost actions → gradual return to mid-teens EBITDA expansion and revenue stabilization.
For historical context on company strategy, ownership and business model see: Cyient Limited: History, Ownership, Mission, How It Works & Makes Money

Cyient Limited (CYIENT.NS) - Growth Opportunities

Cyient's strategic moves and recent financials point to targeted growth avenues even as near-term profitability showed a modest contraction. The carve-out of its semiconductor business into a wholly owned subsidiary, Cyient Semiconductors Private Limited, creates a focused vehicle to scale semiconductor design and manufacturing services, unlock specialized capital allocation, and pursue partner or JV-led expansions in a high-growth segment.
  • Carve-out: Cyient Semiconductors Private Limited - enables focused investments, potential external partnerships, and clearer valuation for semiconductor assets.
  • Capital return and investor confidence: Interim dividend of ₹16 per equity share declared in Q2 FY26 despite profit pressure - signals board confidence in cash flows and shareholder returns.
  • Operational focus: Reallocation of resources toward high-margin engineering and digital services aligned with global industrial, aerospace & defense, and semiconductor demand.
Metric FY24 (₹ crore) FY25 (₹ crore) YoY change
Profit Before Tax (Consolidated) 9,180.3 8,750.0 -4.7%
Interim dividend (per share) - ₹16 (Q2 FY26) Declared despite profit decline
Key structural move - Carve-out: Cyient Semiconductors Private Limited Creates standalone semiconductor unit
Key investor considerations and near-term opportunities:
  • Re-rating potential from the semiconductor carve-out if the subsidiary demonstrates standalone revenue growth, margin expansion, or attracts strategic partnerships.
  • Dividend policy consistency: The ₹16 interim dividend in Q2 FY26 may support investor yield expectations and offset short-term PBT volatility.
  • Margin management: A 4.7% PBT decline to ₹8,750 crore in FY25 highlights the need to monitor cost controls and revenue mix shifts toward higher-value digital/engineering services.
  • Capital allocation: Watch for reinvestment into the semiconductor unit versus buybacks/dividends - the balance will shape medium-term EPS trajectory.
For background context on the company's origins, structure and business model, see: Cyient Limited: History, Ownership, Mission, How It Works & Makes Money

DCF model

Cyient Limited (CYIENT.NS) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.